Navigation Links
Women Alerted against "Natural Hormone Replacement Therapy"

Doctors are urging women to avoid so-called natural hormone replacement therapy because of health concerns surrounding the therapy.//

The therapy, also referred to as bio-identical hormones, has led to elevated hormone levels in some women who underwent that therapy. This in turn could lead to excessive bleeding, blood clots and increased risk of breast and uterine cancer.

According to Dr John Eden, director of the Sydney Menopause Centre at Randwick's Royal Hospital for Women, he had referred two cases of uterine cancer in patients who had been taking natural hormone replacement therapy, to the Therapeutic Goods Administration in the past year alone. Dr Eden has alleged that these "handmade hormones" were synthesized by compounding chemists without proper scrutiny. In spite of the process being legal, it is beyond the regulatory control of the TGA and state-based pharmacy boards.

He said, "There's a whole stack of women being treated out there with handmade hormones. It's untested hormone replacement therapy.Many women think they are getting a herbal treatment and are shocked to learn they are getting a hormone treatment."

Professional Compounding Chemists of Australia, one of the NHRT's major wholesalers, defended the practice, citing an exemption in the TGA Act that allows the preparation of medicines for individuals.

However, PCCA has acknowledged in a written statement that there was no formal testing of the products.

In the statement they said, "Since compounded products are made on an individual basis according to the needs of a specific patient, it is not possible to test each product before supply to a patient without making the cost prohibitive. Many pharmacies do test samples of products that are made frequently."

These chemists usually make the medication in the form of troches, or lozenges, with the hormones absorbed through the lining of the mouth.

The hormones estrogen and progesterone obtained from yams or soy and prepared in laboratories is present in the NHRT. In addition NHRT can also include the male hormone testosterone that has not been approved in Australia for use on women.

Certain therapies even include thyroid hormone, the controversial sex steroid pregnenolone as well as a steroid called DHEA, that converts to testosterone and is banned from manufacture in Australia.

Dr Helena Teede, research director at Australia's leading women's health organization, the Jean Hailes Foundation has said that many women were not aware that these preparations were not approved by the TGA.

She said, "There has been very limited research into these preparations and women taking the compounds are essentially guinea pigs."


'"/>




Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2017)... Freedom, PA (PRWEB) , ... April 22, 2017 ... ... healthcare experience to his role as Vice President of Sales and Business Development ... of key GPO/IDN business partner engagements, business development, and strategic planning for the ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to announce ... the 2017 London Marathon. Set to take place on April 23rd, the London Marathon has ... Schwartz will run as part of team EMPOWER, raising money for the international charity, Smile ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of ... with the 2017 Ruth Ravich Patient Advocacy Award in recognition of her ... was honored with the award at The Beryl Institute’s annual Patient Experience Conference ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/19/2017)... OAKS, Calif. , April 19, 2017 /PRNewswire/ ... industrial buildings it is developing at Conejo Spectrum ... , to Atara Biotherapeutics, Inc. , ... with severe and life-threatening diseases that have been ... on allogeneic T-cell therapies for cancer, autoimmune and ...
Breaking Medicine Technology: